title: Arterial microcalcification in atherosclerotic patients with and without chronic kidney disease: a comparative high-resolution scanning X-ray diffraction analysis.
abstract: Vascular calcification, albeit heterogeneous in terms of biological and physicochemical properties, has been associated with ageing, lifestyle, diabetes, and chronic kidney disease (CKD). It is unknown whether or not moderately impaired renal function (CKD stages 2-4) affects the physiochemical composition and/or the formation of magnesium-containing tricalcium phosphate ([Ca,Mg](3)[PO(4)](2), whitlockite) in arterial microcalcification. Therefore, a high-resolution scanning X-ray diffraction analysis (European Synchrotron Radiation Facility, Grenoble, France) utilizing histological sections of paraffin-embedded arterial specimens derived from atherosclerotic patients with normal renal function (n = 15) and CKD (stages 2-4, n = 13) was performed. This approach allowed us to spatially assess the contribution of calcium phosphate (apatite) and whitlockite to arterial microcalcification. Per group, the number of samples (13 vs. 12) with sufficient signal intensity and total lengths of regions (201 vs. 232 μm) giving rise to diffractograms ("informative regions") were comparable. Summarizing all informative regions per group into one composite sample revealed calcium phosphate/apatite as the leading mineral phase in CKD patients, whereas in patients with normal renal function the relative contribution of whitlockite and calcium phosphate/apatite was on the same order of magnitude (CKD, calcium phosphate/apatite 157 μm, whitlockite 38.7 μm; non-CKD, calcium phosphate/apatite 79.0 μm, whitlockite 94.1 μm; each p < 0.05). Our results, although based on a limited number of samples, indicate that chronic impairment of renal function affects local magnesium homeostasis and thus contributes to the physicochemical composition of microcalcification in atherosclerotic patients.
authors.affiliation: Department of Pediatrics, University Children's Hospital Rostock, Ernst-Heydemann-Str. 8, 18057, Rostock, Germany. dagmar-christiane.fischer@med.uni-rostock.de
authors.forename: Dagmar-Christiane
authors.initials: DC
authors.lastname: Fischer
authors.forename: Geert J
authors.initials: GJ
authors.lastname: Behets
authors.forename: Oliver W
authors.initials: OW
authors.lastname: Hakenberg
authors.forename: Mathias
authors.initials: M
authors.lastname: Voigt
authors.forename: Benjamin A
authors.initials: BA
authors.lastname: Vervaet
authors.forename: Stef
authors.initials: S
authors.lastname: Robijn
authors.forename: Günther
authors.initials: G
authors.lastname: Kundt
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Schareck
authors.forename: Patrick C
authors.initials: PC
authors.lastname: D'Haese
authors.forename: Dieter
authors.initials: D
authors.lastname: Haffner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002130:Calcium Phosphates / Q000378:metabolism; D002339:Carotid Arteries / Q000473:pathology*; D002340:Carotid Artery Diseases / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013052:Spectrometry, X-Ray Emission; D061205:Vascular Calcification / Q000209:etiology* / Q000473:pathology; D014961:X-Ray Diffraction
chemical_list: D002130:Calcium Phosphates; C018392:tricalcium phosphate